144 related articles for article (PubMed ID: 2874568)
1. The effects of cysteamine on dopamine-mediated behaviors: evidence for dopamine-somatostatin interactions in the striatum.
Martin-Iverson MT; Radke JM; Vincent SR
Pharmacol Biochem Behav; 1986 Jun; 24(6):1707-14. PubMed ID: 2874568
[TBL] [Abstract][Full Text] [Related]
2. Intra-cerebral cysteamine infusions attenuate the motor response to dopaminergic agonists.
Lee N; Radke JM; Vincent SR
Behav Brain Res; 1988 Jul; 29(1-2):179-83. PubMed ID: 2900014
[TBL] [Abstract][Full Text] [Related]
3. Dopaminergic substrates of amphetamine-induced place preference conditioning.
Spyraki C; Fibiger HC; Phillips AG
Brain Res; 1982 Dec; 253(1-2):185-93. PubMed ID: 6817850
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of amphetamine-stereotypy by mesostriatal dopamine depletion enhances plasma corticosterone: implications for stereotypy as a coping response.
Jones GH; Mittleman G; Robbins TW
Behav Neural Biol; 1989 Jan; 51(1):80-91. PubMed ID: 2705984
[TBL] [Abstract][Full Text] [Related]
5. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum.
Kelly PH; Seviour PW; Iversen SD
Brain Res; 1975 Sep; 94(3):507-22. PubMed ID: 1171714
[TBL] [Abstract][Full Text] [Related]
6. Evidence that apomorphine and (+)-amphetamine produce different types of circling in rats.
Cools AR; Scheenen W; Eilam D; Golani I
Behav Brain Res; 1989 Aug; 34(1-2):111-6. PubMed ID: 2765168
[TBL] [Abstract][Full Text] [Related]
7. The locomotor and stereotype response to dopaminergic drugs and caffeine after intracerebroventricular kainic acid in rats.
Kleinrok Z; Turski L; Wawrzyniak M; Cybulska R
Pol J Pharmacol Pharm; 1981; 33(2):149-59. PubMed ID: 7198226
[TBL] [Abstract][Full Text] [Related]
8. Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum.
Cenci MA; Kalén P; Mandel RJ; Wictorin K; Björklund A
Neuroscience; 1992; 46(4):943-57. PubMed ID: 1347413
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of ceruletide on amphetamine-induced behaviors and regional dopamine release in the rat.
Kihara T; Ikeda M; Matsubara K; Matsushita A
Eur J Pharmacol; 1993 Jan; 230(3):271-7. PubMed ID: 8440305
[TBL] [Abstract][Full Text] [Related]
10. Long-lasting dopamine receptor up-regulation in amphetamine-treated rats following amphetamine neurotoxicity.
Fields JZ; Wichlinski L; Drucker GE; Engh K; Gordon JH
Pharmacol Biochem Behav; 1991 Dec; 40(4):881-6. PubMed ID: 1816575
[TBL] [Abstract][Full Text] [Related]
11. The effects of some atypical neuroleptics on apomorphine-induced behaviors as a measure of their relative potencies in blocking presynaptic versus postsynaptic dopamine receptors.
Robertson A; MacDonald C
Pharmacol Biochem Behav; 1986 Jun; 24(6):1639-43. PubMed ID: 2874567
[TBL] [Abstract][Full Text] [Related]
12. Peter H. Kelly, Paul W. Seviour and Susan D. Iversen (1975) "Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum" [Brain Res. 94 (3) 507-522].
Iversen SD
Brain Res; 2016 Aug; 1645():36-7. PubMed ID: 27287245
[TBL] [Abstract][Full Text] [Related]
13. Subsensitivity to dopaminergic drugs in periadolescent rats: a behavioral and neurochemical analysis.
Bolanos CA; Glatt SJ; Jackson D
Brain Res Dev Brain Res; 1998 Nov; 111(1):25-33. PubMed ID: 9804875
[TBL] [Abstract][Full Text] [Related]
14. Do forebrain structures compete for behavioral expression? Evidence from amphetamine-induced behavior, microdialysis, and caudate-accumbens lesions in medial frontal cortex damaged rats.
Whishaw IQ; Fiorino D; Mittleman G; Castañeda E
Brain Res; 1992 Mar; 576(1):1-11. PubMed ID: 1381257
[TBL] [Abstract][Full Text] [Related]
15. In vivo electrochemical and behavioral evidence for specific neural substrates modulated differentially by enkephalin in rat stimulant stereotypy and locomotion.
Broderick PA; Gardner EL; van Praag HM
Biol Psychiatry; 1984 Jan; 19(1):45-54. PubMed ID: 6538442
[TBL] [Abstract][Full Text] [Related]
16. Neurochemical evidence that cysteamine modulates amphetamine-induced dopaminergic neuronal activity in striatum by decreasing dopamine release: an in vivo microdialysis study in freely moving rats.
Rakovska A; Javitt D; Petkova-Kirova P; Balla A; Ang R; Kalfin R
Brain Res Bull; 2019 Nov; 153():39-46. PubMed ID: 31401065
[TBL] [Abstract][Full Text] [Related]
17. The amphetamine conditioned place preference: differential involvement of dopamine receptor subtypes and two dopaminergic terminal areas.
Hiroi N; White NM
Brain Res; 1991 Jun; 552(1):141-52. PubMed ID: 1833032
[TBL] [Abstract][Full Text] [Related]
18. Stereotypy, locomotor and cataleptic effects produced by drugs influencing dopaminergic systems in a mutant strain of Wistar rats: a genuine model of basal ganglia dysfunction?
Turski L; Schwarz M; Sontag KH
Behav Brain Res; 1984 Apr; 12(1):29-37. PubMed ID: 6539616
[TBL] [Abstract][Full Text] [Related]
19. Locomotor activation induced by MK-801 in the rat: postsynaptic interactions with dopamine receptors in the ventral striatum.
Ouagazzal A; Nieoullon A; Amalric M
Eur J Pharmacol; 1994 Jan; 251(2-3):229-36. PubMed ID: 8149978
[TBL] [Abstract][Full Text] [Related]
20. Stimulatory role of prolactin on the development of tuberoinfundibular dopaminergic neurones in prepubertal female rats: studies with cysteamine and somatostatin.
Shieh KR; Pan JT
J Neuroendocrinol; 1999 Dec; 11(12):907-17. PubMed ID: 10583725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
